Article
Retina Roundtable Session 1
Subscribe
In this first session, the experts discuss their standard approach when using ranibizumab (Lucentis, Genentech) to treat their patients with age-related macular degeneration.
Participants include:
Return to Retina Roundtable Podcast Series
Return to Ophthalmology Times Radio
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
